$2.28
6.54% day before yesterday
Nasdaq, Dec 27, 09:36 pm CET
ISIN
US1511901050
Symbol
CELU

Celularity Inc - Ordinary Shares - Class A Stock price

$2.24
+0.23 11.44% 1M
-0.56 20.00% 6M
-0.23 9.46% YTD
+0.55 32.23% 1Y
-47.86 95.53% 3Y
-97.26 97.75% 5Y
-95.76 97.71% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.10 4.67%
ISIN
US1511901050
Symbol
CELU
Sector
Industry

Key metrics

Market capitalization $50.36m
Enterprise Value $119.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.47
P/S ratio (TTM) P/S ratio 1.04
P/B ratio (TTM) P/B ratio 2.85
Revenue growth (TTM) Revenue growth 225.94%
Revenue (TTM) Revenue $48.20m
EBIT (operating result TTM) EBIT $-39.92m
Free Cash Flow (TTM) Free Cash Flow $-13.02m
Cash position $130.00k
EPS (TTM) EPS $-1.56
Short interest 25.13%
Show more

Is Celularity Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Celularity Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Celularity Inc - Ordinary Shares - Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Celularity Inc - Ordinary Shares - Class A:

Buy
100%

Financial data from Celularity Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
48 48
226% 226%
100%
- Direct Costs 26 26
21% 21%
53%
23 23
457% 457%
47%
- Selling and Administrative Expenses 54 54
15% 15%
112%
- Research and Development Expense - -
-
-
-32 -32
64% 64%
-66%
- Depreciation and Amortization 8.34 8.34
12% 12%
17%
EBIT (Operating Income) EBIT -40 -40
59% 59%
-83%
Net Profit -35 -35
81% 81%
-73%

In millions USD.

Don't miss a Thing! We will send you all news about Celularity Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Celularity Inc - Ordinary Shares - Class A Stock News

Neutral
GlobeNewsWire
19 days ago
FLORHAM PARK, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it has received a letter from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”), confirming that Celularity has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”). ...
Neutral
GlobeNewsWire
23 days ago
FLORHAM PARK, N.J., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024. With this filing, the Company is now current on its quarterly report filings.
Neutral
GlobeNewsWire
about one month ago
FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc.  (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that on November 21, 2024, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) ...
More Celularity Inc - Ordinary Shares - Class A News

Company Profile

Celularity, Inc. a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The firms CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. The company is headquartered in Florham Park, NJ.

Head office United States
CEO Robert Gordon
Employees 120
Founded 2016
Website www.celularity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today